- Home
- DNTH vs CLBK Comparison
DNTH vs CLBK Comparison
Compare DNTH & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- CLBK
- Stock Information
- Founded
- DNTH 2015
- CLBK 1927
- Country
- DNTH United States
- CLBK United States
- Employees
- DNTH N/A
- CLBK N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- CLBK Savings Institutions
- Sector
- DNTH Health Care
- CLBK Finance
- Exchange
- DNTH Nasdaq
- CLBK Nasdaq
- Market Cap
- DNTH 1.4B
- CLBK 1.5B
- IPO Year
- DNTH N/A
- CLBK N/A
- Fundamental
- Price
- DNTH $33.67
- CLBK $15.33
- Analyst Decision
- DNTH Strong Buy
- CLBK Hold
- Analyst Count
- DNTH 11
- CLBK 1
- Target Price
- DNTH $65.22
- CLBK $16.00
- AVG Volume (30 Days)
- DNTH 516.1K
- CLBK 134.9K
- Earning Date
- DNTH 11-07-2025
- CLBK 10-20-2025
- Dividend Yield
- DNTH N/A
- CLBK N/A
- EPS Growth
- DNTH N/A
- CLBK N/A
- EPS
- DNTH N/A
- CLBK 0.15
- Revenue
- DNTH $4,854,000.00
- CLBK $202,015,000.00
- Revenue This Year
- DNTH N/A
- CLBK $33.24
- Revenue Next Year
- DNTH N/A
- CLBK $12.96
- P/E Ratio
- DNTH N/A
- CLBK $102.91
- Revenue Growth
- DNTH 17.87
- CLBK 0.49
- 52 Week Low
- DNTH $13.37
- CLBK $12.64
- 52 Week High
- DNTH $40.16
- CLBK $19.28
- Technical
- Relative Strength Index (RSI)
- DNTH 46.99
- CLBK 55.93
- Support Level
- DNTH $32.28
- CLBK $14.58
- Resistance Level
- DNTH $35.40
- CLBK $15.29
- Average True Range (ATR)
- DNTH 1.59
- CLBK 0.42
- MACD
- DNTH -0.20
- CLBK 0.04
- Stochastic Oscillator
- DNTH 26.53
- CLBK 88.55
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About CLBK Columbia Financial Inc.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.